Optimization of antibiotic and antimycotic compositions for the eradication of microorganisms from cell cultures

Cell cultures underlie the vast majority of in vitro research. Despite strict sterility requirements and the availability of high-tech equipment to prevent contamination, laboratory practice remains associated with a significant risk of contamination of mammalian cell cultures with bacterial and fungal agents. According to the American Type Culture Collection (ATCC), 15–35% of cell lines are contaminated with mycoplasma, posing a high risk of cross-contamination and leading to significant distortions of the experimental data obtained using such cultures. Furthermore, microbial contamination is a major risk factor when working with cell cultures isolated from patient surgical biospecimens. Despite the availability of ready-made solutions for eradicating microorganisms and preventing cell culture contamination, the problem of antibiotic resistance is particularly relevant for such contamination, and commercially available agents are often ineffective. In this study, combinations of antimicrobial agents were selected to address two of the most common practical challenges in cell culture: (i) complete elimination of mycoplasma infection and (ii) preventing contamination of primary cell cultures with bacteria and fungi that are components of the patient microbiome. A combination of tylosin, tetracycline, ciprofloxacin, erythromycin, and chloramphenicol was shown to completely eradicate mycoplasma from infected cell cultures. A combination of levofloxacin, polymyxin B, vancomycin, meropenem, and the antifungals micafungin and voriconazole completely eliminated the risk of microbial contamination during primary culture isolation, including from complex specimens such as surgical resections from colorectal cancer patients. The selected compositions successfully combine low cytotoxicity with a broad spectrum of antimicrobial activity, allowing for their effective use in laboratory practice. Nonetheless, the principle of minimizing the use of antimicrobial agents should be strictly adhered to in order to control the spread of antibiotic resistance.

Authors

Institutions

Publication Details

Journal
Acta Naturae
Published
2026-10-27
DOI
https://doi.org/10.32607/actanaturae.27907
Primary Topic
Microbial infections and disease research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimization of antibiotic and antimycotic compositions for the eradication of microorganisms from cell cultures

Stanislav S. Terekhov, P. V. Tsarapaev, Н. Е. Кушлинский, Alexander G. Gabibov et al.
Acta Naturae
Microbial infections and disease research
article

Optimization of antibiotic and antimycotic compositions for the eradication of microorganisms from cell cultures

Stanislav S. Terekhov, P. V. Tsarapaev, Н. Е. Кушлинский, Alexander G. Gabibov, O. V. Serova, N. Gong, Y. A. Prokopenko, E. A. Faizullina, I. V. Smirnov, Y. A. Mokrushina, S. V. Protsenko, H. Zhang, Y. B. Kuzmin, H. Zheng, Y. R. Vereveiko, D. M. Malabuyok
article en

Abstract

Cell cultures underlie the vast majority of in vitro research. Despite strict sterility requirements and the availability of high-tech equipment to prevent contamination, laboratory practice remains associated with a significant risk of contamination of mammalian cell cultures with bacterial and fungal agents. According to the American Type Culture Collection (ATCC), 15–35% of cell lines are contaminated with mycoplasma, posing a high risk of cross-contamination and leading to significant distortions of the experimental data obtained using such cultures. Furthermore, microbial contamination is a major risk factor when working with cell cultures isolated from patient surgical biospecimens. Despite the availability of ready-made solutions for eradicating microorganisms and preventing cell culture contamination, the problem of antibiotic resistance is particularly relevant for such contamination, and commercially available agents are often ineffective. In this study, combinations of antimicrobial agents were selected to address two of the most common practical challenges in cell culture: (i) complete elimination of mycoplasma infection and (ii) preventing contamination of primary cell cultures with bacteria and fungi that are components of the patient microbiome. A combination of tylosin, tetracycline, ciprofloxacin, erythromycin, and chloramphenicol was shown to completely eradicate mycoplasma from infected cell cultures. A combination of levofloxacin, polymyxin B, vancomycin, meropenem, and the antifungals micafungin and voriconazole completely eliminated the risk of microbial contamination during primary culture isolation, including from complex specimens such as surgical resections from colorectal cancer patients. The selected compositions successfully combine low cytotoxicity with a broad spectrum of antimicrobial activity, allowing for their effective use in laboratory practice. Nonetheless, the principle of minimizing the use of antimicrobial agents should be strictly adhered to in order to control the spread of antibiotic resistance.

Acta NaturaeVol. 18(3)
Lomonosov Moscow State University (RU), Nankai University (CN), Endocrinology Research Center (RU), Russian Cancer Research Center NN Blokhin (RU), Institute of Bioorganic Chemistry (RU), Ministry of Health of the Russian Federation (RU), Ministry of Health (MN)
Good health and well-being
Openalex Percentile: Top 14%
Microbial infections and disease research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon